These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2569216)

  • 1. Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the rat.
    Parashos SA; Barone P; Marin CA; Paraschos AJ; Kapitzoglou-Logothetis V; Chase TN
    Psychopharmacology (Berl); 1989; 98(2):189-92. PubMed ID: 2569216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
    Butkerait P; Friedman E
    Eur J Pharmacol; 1988 Mar; 148(2):269-72. PubMed ID: 2897925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390.
    Vaccheri A; Dall'Olio R; Gandolfi O; Roncada P; Montanaro N
    Psychopharmacology (Berl); 1987; 91(3):394-6. PubMed ID: 2882541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity.
    Marin C; Parashos SA; Kapitzoglou-Logothetis V; Peppe A; Chase TN
    Pharmacol Biochem Behav; 1993 May; 45(1):195-200. PubMed ID: 8516358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated treatment with (-)-sulpiride plus a low dose of SCH 23390 displays wider neuroleptic activity without inducing dopaminergic supersensitivity.
    Dall'Olio R; Gandolfi O; Roncada P; Vaccheri A; Montanaro N
    Psychopharmacology (Berl); 1990; 100(4):560-2. PubMed ID: 1969667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.
    Glenthøj B
    Psychopharmacology (Berl); 1993; 113(2):157-66. PubMed ID: 7855176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.
    Jenner P; Rupniak NM; Hall MD; Dyer R; Leigh N; Marsden CD
    Eur J Pharmacol; 1981 Nov; 76(1):31-6. PubMed ID: 6119220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic activity of ascorbic acid (vitamin C) on dopaminergic modulation: apomorphine-induced stereotypic behavior in mice.
    Deshpande C; Dhir A; Kulkarni SK
    Pharmacology; 2006; 77(1):38-45. PubMed ID: 16569938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal synaptophysin levels are not indicative of dopaminergic supersensitivity.
    Marin C; Tolosa E
    Neuropharmacology; 1997 Aug; 36(8):1115-7. PubMed ID: 9294977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection of apomorphine--a test to predict individual different dopaminergic sensitivity?
    Surmann A; Havemann-Reinecke U
    J Neural Transm Suppl; 1995; 45():143-55. PubMed ID: 8748620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential alteration in striatal dopaminergic and cortical serotonergic receptors induced by repeated administration of haloperidol or centbutindole in rats.
    Gulati A; Srimal RC; Dhawan BN
    Pharmacology; 1988; 36(6):396-404. PubMed ID: 2901759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diazepam attenuates the antagonism of haloperidol against apomorphine-induced stereotypic behavior after subchronic but not acute treatment in rats.
    Fuchs V; Coper H; Strauss S; Rommelspacher H
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):133-7. PubMed ID: 3024028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of buspirone on dopaminergic supersensitivity.
    Queiroz CM; Frussa-Filho R
    Life Sci; 1997; 61(4):371-82. PubMed ID: 9244363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of dopaminergic supersensitivity by a single dose of amphetamine.
    Haracz JL; Tseng LF
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):131-3. PubMed ID: 6106902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic haloperidol treatment potentiates apomorphine- and ethanol-induced hypothermia in the rat.
    Lai H; Kazi MS; Carino MA; Horita A
    Life Sci; 1982 Mar; 30(10):821-6. PubMed ID: 7200179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of apomorphine administration on rearing activity of control and experimental rats withdrawn from long-term haloperidol treatment.
    Bernardi MM; Palermo-Neto J
    Gen Pharmacol; 1984; 15(4):363-5. PubMed ID: 6541605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
    Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR
    Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The problem of antipsychotic treatment for functional imaging in Huntington's disease: receptor binding, gene expression and locomotor activity after sub-chronic administration and wash-out of haloperidol in the rat.
    Besret L; Page KJ; Dunnett SB
    Brain Res; 2000 Jan; 853(1):125-35. PubMed ID: 10627316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.